Indaptus Therapeutics, Inc. Common Stock (NASDAQ: INDP) last traded at $2.44, down 2.79% on the session. The quote above updates while this page is open; the figures below are drawn from Indaptus Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Indaptus Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker INDP. Its market capitalisation is $325.11 million.
Valuation measures for Indaptus Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $325.11M |
|---|---|
| Enterprise value | $318.17M |
| Price / book | 28.59 |
| Beta | 1.81 |
Trailing-twelve-month figures tagged in Indaptus Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$15.42M |
| Return on equity | -135.62% |
|---|
| Cash | $7.55M |
|---|
Range and volume for INDP over the past 52 weeks.
| 52-week high | $5.96 |
|---|---|
| 52-week low | $0.920 |
| Volume | 297.2K |
| Average volume | 834.2K |
| Previous close | $2.51 |
Invest a chosen dollar amount in Indaptus Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell INDP.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.